Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Short term Debt (2022 - 2025)

Historic Short term Debt for Trinity Biotech (TRIB) over the last 5 years, with Q2 2025 value amounting to $1.1 million.

  • Trinity Biotech's Short term Debt fell 2285.32% to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year decrease of 2285.32%. This contributed to the annual value of $1.7 million for FY2024, which is 21520.91% up from last year.
  • Trinity Biotech's Short term Debt amounted to $1.1 million in Q2 2025, which was down 2285.32% from $1.7 million recorded in Q4 2024.
  • Over the past 5 years, Trinity Biotech's Short term Debt peaked at $2.0 million during Q2 2022, and registered a low of $526000.0 during Q4 2023.
  • Moreover, its 4-year median value for Short term Debt was $1.4 million (2024), whereas its average is $1.3 million.
  • Per our database at Business Quant, Trinity Biotech's Short term Debt skyrocketed by 21520.91% in 2024 and then crashed by 2285.32% in 2025.
  • Over the past 4 years, Trinity Biotech's Short term Debt (Quarter) stood at $2.0 million in 2022, then plummeted by 73.73% to $526000.0 in 2023, then soared by 215.21% to $1.7 million in 2024, then plummeted by 32.81% to $1.1 million in 2025.
  • Its Short term Debt stands at $1.1 million for Q2 2025, versus $1.7 million for Q4 2024 and $1.4 million for Q2 2024.